Bristol-Myers Squibb
- A07 - Antidiarreicos, antiinfecciosos y antiinflamatorios intestinales
- MYCOSTATIN oral suspension 100 000 IU/ml
- A10 - Antidiabéticos
- ONGLYZA film-coated tablet 5 mg
- B01 - Agentes antitrombóticos
- ISCOVER film-coated tablet 75 mg
- C09 - Agentes activos sobre el sistema renina-angiotensina
- CAPOTEN tablet 25 mg
- CAPOTEN tablet 50 mg
- FOSITEN PLUS tablet 20 mg+12.5 mg
- FOSITEN tablet 20 mg
- LOPIRETIC tablet 50 mg+25 mg
- C10 - Agentes modificadores de los lípidos
- PRAVACOL tablet 20 mg
- PRAVACOL tablet 40 mg
- QUANTALAN powder for oral suspension 4 g
- J01 - Antibacterianos para uso sistémico
- AZACTAM powder and solvent for solution for injection 1 g+3 ml
- BICLIN powder and solvent for solution for injection 500 mg+2 ml
- DICLOCIL capsule, hard 500 mg
- MAXIPIME powder for solution for injection 1 g
- PROCEF oral suspension 250 mg/5 ml
- PROCEF tablet 500 mg
- RADACEFE powder for oral suspension 250 mg/5 ml
- RADACEFE tablet 500 mg
- J02 - Antimicóticos de uso sistémico
- FUNGIZONE powder for solution for infusion 50 mg
- J05 - Antivirales de uso sistémico
- BARACLUDE film-coated tablet 0.5 mg
- BARACLUDE film-coated tablet 1 mg
- BARACLUDE oral solution 0.05 mg/ml
- REYATAZ capsule, hard 150 mg
- REYATAZ capsule, hard 200 mg
- REYATAZ capsule, hard 300 mg
- VIDEX chewable tablet 100 mg
- VIDEX chewable tablet 25 mg
- VIDEX gastro-resistant capsule, hard 125 mg
- VIDEX gastro-resistant capsule, hard 200 mg
- VIDEX gastro-resistant capsule, hard 250 mg
- VIDEX gastro-resistant capsule, hard 400 mg
- ZERIT capsule, hard 15 mg
- ZERIT capsule, hard 20 mg
- ZERIT capsule, hard 30 mg
- ZERIT capsule, hard 40 mg
- ZERIT powder for oral suspension 1 mg/ml
- L01 - Antineoplásicos
- HYDREA capsule, hard 500 mg
- SPRYCEL film-coated tablet 100 mg
- SPRYCEL film-coated tablet 20 mg
- SPRYCEL film-coated tablet 50 mg
- SPRYCEL film-coated tablet 70 mg
- TAXOL concentrate for solution for infusion 6 mg/ml
- UFT capsule, hard 100 mg+224 mg
- VEPESID capsule, soft 100 mg
- VEPESID capsule, soft 50 mg
- VUMON solution for infusion 50 mg/5 ml
- YERVOY concentrate for solution for infusion 5 mg/ml
- L02 - Terapia endocrina
- MEGACE oral suspension 40 mg/ml
- MEGACE tablet 160 mg
- L04 - Inmunosupresores
- ORENCIA powder for solution for infusion 250 mg
- M01 - Antiinflamatorios y antirreumáticos
- NIFLURIL capsule, hard 250 mg
- N02 - Analgésicos
- DAFALGAN CODEINA film-coated tablet 500 mg+30 mg
- DAFALGAN effervescent tablet 1 g
- DAFALGAN film-coated tablet 1 g
- EFFERALGAN effervescent tablet 500 mg
- EFFERALGAN ODIS orodispersible tablet 500 mg
- PERFALGAN solution for infusion 10 mg/ml
- N05 - Psicolépticos
- ABILIFY oral solution 1 mg/ml
- ABILIFY solution for injection 7.5 mg/ml
- ABILIFY tablet 10 mg
- ABILIFY tablet 15 mg
- ANATENSOL DECANOATO solution for injection 25 mg/ml
- BUSPAR tablet 10 mg
- BUSPAR tablet 5 mg
- V07 - Todos los demás productos no terapéuticos
- VIASPAN solution for organ preservation